Page last updated: 2024-08-24

simendan and Blood Loss, Postoperative

simendan has been researched along with Blood Loss, Postoperative in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Fu, RQ; He, LX; Lin, Y; Tan, JC; Wang, LH; Wang, XH; Yao, YT1
Deng, QM; Sai, WW; Shang, GK; Song, JW; Song, M; Wang, XY; Wang, ZH; Yan, SB; Zhang, W; Zhong, M1
He, LX; Yao, YT; Zhao, YY1
Lahtinen, P; Musialowicz, T; Pitkänen, O1

Reviews

2 review(s) available for simendan and Blood Loss, Postoperative

ArticleYear
Impact of Perioperative Levosimendan Administration on Risk of Bleeding After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020, Volume: 20, Issue:2

    Topics: Blood Transfusion; Cardiac Surgical Procedures; Cardiotonic Agents; Humans; Perioperative Care; Postoperative Hemorrhage; Randomized Controlled Trials as Topic; Risk; Simendan

2020
The effect of levosimendan on postoperative bleeding and blood transfusion in cardiac surgical patients: a PRISMA-compliant systematic review and meta-analysis.
    Perfusion, 2021, Volume: 36, Issue:7

    Topics: Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedures; Humans; Plasma; Postoperative Hemorrhage; Simendan

2021

Trials

1 trial(s) available for simendan and Blood Loss, Postoperative

ArticleYear
Levosimendan increases bleeding risk after heart valve surgery: a retrospective analysis of a randomized trial.
    Journal of cardiothoracic and vascular anesthesia, 2014, Volume: 28, Issue:5

    Topics: Aged; Aged, 80 and over; Cardiopulmonary Bypass; Cardiotonic Agents; Double-Blind Method; Female; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Pyridazines; Retrospective Studies; Simendan

2014

Other Studies

1 other study(ies) available for simendan and Blood Loss, Postoperative

ArticleYear
Levosimendan administration is not associated with increased risk of bleeding and blood transfusion requirement in patients undergoing off-pump coronary artery bypass grafting: a retrospective study from single center.
    Perfusion, 2023, Volume: 38, Issue:2

    Topics: Blood Transfusion; Coronary Artery Bypass, Off-Pump; Humans; Postoperative Hemorrhage; Retrospective Studies; Simendan; Treatment Outcome

2023